There’s a good chance that our next government will be a coalition, with Jeremy Corbyn at the reins and Brexit delayed indefinitely. John Stepek looks at what that means for your portfolio.
If you're new to investing, but aren't sure how to go about it, MoneyWeek's 'how to invest' pages are the place for you.
Here, you'll find everything you need to know about investing, from the basics, to tips on strategies, building a portfolio, what to buy and asset allocation. We've got videos and articles for all levels, from beginner to advanced.
If you’re new to investing, read these articles first
Four simple but effective ideas for building a portfolio
David C Stevenson’s three-part series on how to set up a long-term regular savings plan using five simple investment trusts.
Having 40 years to invest can free you up to take risks in the big themes of the next few decades, says David C Stevenson. Here, he picks four of the best funds to buy for the long term.
A simple, easy to manage portfolio of our favourite investment trusts, selected by Merryn Somerset Webb, offering defensiveness, stability, exposure to growth, and some income.
All articles on how to invest
ZZZZ Best was a carpet-cleaning company set up in 1982 by 16-year-old Barry Minkow, who would use it to run a Ponzi scheme that netted millions.
A striking gap in the returns on Chinese index funds shows why you must be sure to know what you own. John Stepek explains.
Sigmund Freud was pessimistic, Carl Rogers optimistic, says John Stepek. But it’s through this third great psychologist that investors can hope to better know themselves.
Lots of people will tell you now isn’t a good time to invest. But that’s not true, says Merryn Somerset Webb, there is always value somewhere. Here’s where to find it now.
When analysts tell you one asset is “better” than another, beware. It all rather depends, says Dominic Frisby. A sensibly diversified portfolio will serve you much better than chasing the “best” assets.
Matthew Partridge explains the scam behind Theranos, a fake blood-testing company that raised $700m from investors.